OBJECTIVE: The aims of this study were to determine the prevalence of human papillomavirus (HPV) infection in women treated for infertility and oocyte donors, and to investigate the possible influence of HPV infection on reproductive outcomes. STUDY DESIGN: In this observational laboratory-based study, cervical swabs were collected from oocyte donors (n = 207), and women treated for infertility (n = 945) and analysed for the presence of high-risk HPV (hrHPV) genotypes using the cobas® 4800 HPV Test and PapilloCheck® HPV-Screening. Associations between hrHPV positive status and fertility outcome or socio-behavioral and health characteristics were evaluated using R statistical software. RESULTS: HrHPV prevalence was significantly higher in oocyte donors than in women treated for infertility (28.0% vs. 16.1%, P < 0.001). Women who became pregnant spontaneously (19.6%) and women not treated with in vitro fertilization (IVF, 18.1%) were more frequently hrHPV positive than women treated with IVF (12.7%, P = 0.077). Despite the high prevalence of hrHPV in both oocyte donors and infertile women, no associations between hrHPV positive status and pregnancy or abortion rates were found in IVF treated women or in oocyte recipients. Moreover, no associations between hrHPV positive status and abortion rates were found in spontaneously pregnant women. CONCLUSION: Despite the high prevalence of hrHPV in both oocyte donors and infertile women, HPV infection did not influence the outcomes of assisted reproductive technology.

Arleta IVF Ltd Kostelec nad Orlici 517 41 Czech Republic

Cancer Research Czech Republic Olomouc 77900 Czech Republic

Fertimed Ltd Olomouc 77600 Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc 77900 Czech Republic

See more in PubMed

Boivin J., Bunting L., Collins J.A., Nygren K.G. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22:1506–1512. PubMed

Mascarenhas M.N., Cheung H., Mathers C.D., Stevens G.A. Measuring infertility in populations: constructing a standard definition for use with demographic and reproductive health surveys. Popul Health Metr. 2012;10(17) PubMed PMC

Pellati D., Mylonakis I., Bertoloni G., Fiore C., Andrisani A., Ambrosini G. Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol. 2008;140:3–11. PubMed

Dejucq N., Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65:208–231. PubMed PMC

Kapranos N., Petrakou E., Anastasiadou C., Kotronias D. Detection of herpes simplex virus, cytomegalovirus, and Epstein-Barr virus in the semen of men attending an infertility clinic. Fertil Steril. 2003;79(Suppl 3):1566–1570. PubMed

Forman D., de MC Lacey C.J., Soerjomataram I., Lortet-Tieulent J., Bruni L. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–F23. PubMed

Rosales R., Rosales C. Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol. 2014;5:1002–1019. PubMed PMC

Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907. PubMed

Gizzo S., Ferrari B., Noventa M., Ferrari E., Patrelli T.S., Gangemi M. Male and couple fertility impairment due to HPV-DNA sperm infection: update on molecular mechanism and clinical impact--systematic review. Biomed Res Int. 2014;2014 PubMed PMC

Souho T., Benlemlih M., Bennani B. Human papillomavirus infection and fertility alteration: a systematic review. PLoS One. 2015;10:e0126936. PubMed PMC

GmbH RD . Roche Molecular Systems Inc; 2012. Cobas® 4800 HPV test.

Jaworek H., Koudelakova V., Drabek J., Vrbkova J., Zborilova B., Oborna I. A head-to-Head analytical comparison of cobas 4800 HPV, PapilloCheck HPV screening, and LMNX genotyping kit HPV GP for detection of human papillomavirus DNA in cervical and cervicovaginal swabs. J Mol Diagn. 2018;20:849–858. PubMed

GmbH . 2012. PapilloCheck® high-risk. Greiner bio-one.

2014. BV. LMNX kit HPV GP HR. Diassay.

Strehler E., Sterzik K., Malthaner D., Hoyer H., Nindl I., Schneider A. Influence of ovarian stimulation on the detection of human papillomavirus DNA in cervical scrapes obtained from patients undergoing assisted reproductive techniques. Fertil Steril. 1999;71:815–820. PubMed

Spandorfer S.D., Bongiovanni A.M., Fasioulotis S., Rosenwaks Z., Ledger W.J., Witkin S.S. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril. 2006;86:765–767. PubMed

Lundqvist M., Westin C., Lundkvist O., Simberg N., Strand A., Andersson S. Cytologic screening and human papilloma virus test in women undergoing artificial fertilization. Acta Obstet Gynecol Scand. 2002;81:949–953. PubMed

Perino A., Giovannelli L., Schillaci R., Ruvolo G., Fiorentino F.P., Alimondi P. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertil Steril. 2011;95:1845–1848. PubMed

Yang R., Wang Y., Qiao J., Liu P., Geng L., Guo Y.L. Does human papillomavirus infection do harm to in-vitro fertilization outcomes and subsequent pregnancy outcomes? Chin Med J (Engl) 2013;126:683–687. PubMed

Comar M., Monasta L., Zanotta N., Vecchi B.L., Ricci G., Zauli G. Human papillomavirus infection is associated with decreased levels of GM-CSF in cervico-vaginal fluid of infected women. J Clin Virol. 2013;58:479–481. PubMed

Tachezy R., Smahelova J., Kaspirkova J., Salakova M. Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One. 2013;8:e79156. PubMed PMC

de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–459. PubMed

Bruni L., Diaz M., Castellsague X., Ferrer E., Bosch FX, de S.S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–1799. PubMed

Guan P., Howell-Jones R., Li N., Bruni L., de SS, Franceschi S. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–2359. PubMed

Tachezy R., Hamsikova E., Hajek T., Mikyskova I., Smahel M., Van R.M. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol. 1999;58:378–386. PubMed

Ondryasova H., Koudelakova V., Drabek J., Vanek P., Slavkovsky R., Hajduch M. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study] Ceska Gynekol. 2015;80:436–443. PubMed

Conde-Ferraez L., Chan May A.A., Carrillo-Martinez J.R., Ayora-Talavera G., Gonzalez-Losa M.R. Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico. Eur J Obstet Gynecol Reprod Biol. 2013;170:468–473. PubMed

Skoczynski M., Gozdzicka-Jozefiak A., Kwasniewska A. Prevalence of human papillomavirus in spontaneously aborted products of conception. Acta Obstet Gynecol Scand. 2011;90:1402–1405. PubMed

Ticconi C., Pietropolli A., Fabbri G., Capogna M.V., Perno C.F., Piccione E. Recurrent miscarriage and cervical human papillomavirus infection. Am J Reprod Immunol. 2013;70:343–346. PubMed

Hermonat P.L., Han L., Wendel P.J., Quirk J.G., Stern S., Lowery C.L. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes. 1997;14:13–17. PubMed

Gomez L.M., Ma Y., Ho C., McGrath C.M., Nelson D.B., Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod. 2008;23:709–715. PubMed

Ambuhl L.M., Baandrup U., Dybkaer K., Blaakaer J., Uldbjerg N., Sorensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infect Dis Obstet Gynecol. 2016;2016 PubMed PMC

Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study

Prevalence and genotype distribution of human papillomavirus in Czech non-vaccinated heterosexual couples